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Abstract
BLNK is a pivotal adaptor protein in the signal transduction pathway from the IgM class B-cell receptor. BLNK is
phosphorylated by Syk and binds various signaling intermediates, leading to cellular events including MAP-kinase
activation, culminating in cellular activation. It remains unclear how BLNK is initially recruited to the surface IgM (sIgM)
complex to which Syk is also recruited. Here we show that CMTM7, a tetra-spanning membrane protein of unknown
function, co-localized with clathrin and sIgM at the plasma membrane. RNA-interference-mediated knockdown of CMTM7
expression in B cells resulted in an impairment of sIgM-ligation-induced tyrosine phosphorylation of BLNK, which was due
to an impaired interaction of BLNK and Syk, and in a failure to activate JNK and ERK, but not upstream kinases such as Src-
family kinases and Syk. CMTM7 was bound to BLNK in a membrane fraction, and their association was augmented after sIgM
ligation. Exogenous CMTM7 or a mutant with an N-terminal deletion (DN), but not one with a C-terminal deletion (DC) that
is defective in membrane localization, were able to restore BLNK-Syk binding, BLNK phosphorylation and ERK activation in
the CMTM7-knockdown B cells. In addition, CMTM7 and the DN, but not the DC, were constitutively associated with sIgM,
and this binding was required for BLNK recruitment to sIgM. From these data, we conclude that CMTM7 functions to link
sIgM and BLNK in the plasma membrane, to recruit BLNK to the vicinity of Syk, and to initiate the BLNK-mediated signal
transduction.
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Introduction
Upon ligation with antigen, B-cell antigen receptors (BCR)
cluster on the cell surface, rapidly transduce signals into the
cytoplasm, and are eventually internalized with bound antigen,
primarily through a clathrin-mediated endocytosis pathway [1,2].
The BCR on the membrane of naı ¨ve B cells is a complex
composed of surface immunoglobulin M (sIgM) and the signal
transducing subunits, Iga and Igb. Signal transduction is initiated
with the phosphorylation by Src-family kinases such as Lyn of
tyrosine residues in an immunoreceptor tyrosine-based activation
motif (ITAM) contained within the cytoplasmic domains of both
Iga and Igb [3]. Syk is then recruited to the ITAM phosphotyr-
osines, activated and subsequently phosphorylates the adaptor
protein BLNK to which signaling factors such as Btk, phospho-
lipase Cc2 (PLCc2), Vav and Grb2 are recruited through their
SH2 or SH3 domains. Syk then phosphorylates and activates Btk
and Vav, which activate PLCc2 and Rac, respectively. The
activated PLCc2 hydrolyzes phosphatidylinositol 4,5-bisphosphate
into inositol trisphosphate (IP3) and diacyl glycerol (DAG). IP3
triggers Ca
2+ mobilization, while DAG activates Ras through
RasGRP [4,5]. Ras and Rac trigger signaling cascades eventually
activating MAP-kinases such as ERK and JNK. Intracellular
calcium and DAG also activate enzymes such as PKC, which
initiates signaling cascades including those activating NF-kB.
These biochemical events culminate in the activation of transcrip-
tion factors that induce activation, proliferation and/or differen-
tiation of B cells [6].
BLNK (also known as SLP65 or BASH) plays a crucial role in
signal transduction from the BCR, especially of the IgM class, and
the pre-BCR. In BLNK-deficient mice, B-cell development is
markedly affected at both pre-B-cell and immature B-cell stages.
The spleen contains fewer mature B cells than normal, and the B
cells present respond poorly to BCR ligation-induced proliferation
in vitro and the mice also have a defective antibody response to T-
independent type-2 antigens in vivo [7–11]. BLNK-deficient B cells
also have defects in BCR-triggered Ca
2+ flux and activation of
PLCc2, ERK, JNK, p38, and NF-kB [7,8,12,13]. Thus, BLNK
functions as a multivalent adaptor molecule that gathers signaling
intermediates to form a ‘signalosome’ beneath the sIgM complex.
In order to exert its adaptor function, BLNK must first be
recruited to the BCR to be phosphorylated by Syk, which is bound
there to Iga/Igb. However, the mechanism for BLNK recruitment
to the BCR remains unclear. It has been shown that, upon
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204 in mice) of Iga binds
the C-terminal src-homology 2 (SH2) domain of BLNK, and that
this contributes to BLNK phosphorylation upon BCR- or Iga-
crosslinking to various extents depending on the experimental
setting [14–18]. It has also been proposed that BLNK directly
binds to Syk [19] through the BLNK SH2 domain and the C-
terminal region of Syk [20,21]. However, deletion of the SH2
domain resulted only in a modest reduction of tyrosine
phosphorylation of BLNK upon BCR ligation [20], implicating
an SH2 domain-independent mechanism for the interaction of
BLNK with Syk. An N-terminal basic region of BLNK, and most
likely a leucine zipper motif in this region, was shown to be
necessary and sufficient for constitutive association of BLNK with
the plasma membrane [22], although a BLNK variant lacking the
leucine zipper motif could still be phosphorylated by Syk in a T-
cell reconstitution system [20].
We have previously identified CMTM3 (formerly termed
BNAS2) as a binding partner of BLNK [23]. CMTM3 belongs
to a nine-member protein family (CKLF and CMTM1,8) of
unknown function, which have homology to a tetra-spanning
transmembrane domain called MARVEL (MAL and related
protein for vesicle trafficking and membrane linking) [24]. Some of
the MARVEL domain-containing proteins are involved in
cholesterol-rich membrane apposition events, such as biogenesis
of vesicular transport carriers or tight junction regulation, but the
functions of others remain unknown [25]. Genes encoding this
family, except for CMTM5, cluster at two loci on different
chromosomes; CKLF and CMTM1,4 on chromosome 8 in mice
and 16 in humans, and CMTM6,8 on chromosome 9 in mice and
3 in humans. The expression profile of each member shows a
distinctive pattern, with CMTM3 and 7 being expressed selec-
tively in hematopoietic cells. In the course of our study of CMTM3
function, we noted that CMTM7 is also bound with BLNK. Thus
far, no reports have been published about CMTM7 except for one
describing its genomic configuration [24]. Here we report that
CMTM7 is crucial for BCR-induced BLNK interaction with and
phosphorylation by Syk, and for activation of downstream
signaling pathways to ERK and JNK. We propose that CMTM7
functions to connect sIgM and BLNK, thus facilitating formation
of the BLNK-nucleated sIgM signalosome.
Results
CMTM7 is localized at the plasma membrane in
association with clathrin and surface IgM
To clarify the localization of CMTM7 in mammalian cells, we
transfected HeLa cells with a T7 epitope-tagged human CMTM7
expression construct and stained the cells with anti-T7 antibody
together with antibodies against various organelle markers.
Confocal microscopy revealed that CMTM7 is co-localized with
clathrin accumulating near the plasma membrane, presumably
representing clathrin-coated pits and vesicles, in a perinuclear
region partly overlapping with the Golgi apparatus, and also with
some early endosomes, whereas there was no apparent co-
localization with the endoplasmic reticulum (ER) marker calnexin
(Figure 1A). To clarify the membrane topology of CMTM7,
HEK293T cells were transfected with expression constructs
encoding mouse CMTM7 tagged with HA or FLAG epitopes at
N- or C-termini, respectively. Both epitopes could be detected with
specific antibodies by flow cytometry on non-permeabilized cells
(Figure 1B), indicating that both the N- and C-terminal moieties
of CMTM7 are exposed outside of cells.
To confirm the plasma membrane localization of CMTM7 in
B cells and examine possible changes in localization dynamics
after ligation of surface IgM (sIgM), we made a mouse B-cell
lymphoma cell line, BAL17, stably transfected with an expression
construct encoding T7-tagged mouse CMTM7 (BAL17/T7-
CMTM7). The intact BAL17/T7-CMTM7 cells were stained
with anti-T7 and anti-IgM antibodies and cultured at 37uCt o
allow the ligation-mediated reorganization of sIgM and its
subsequent signaling. Before the culture, CMTM7 was clearly
detected at plasma membrane, co-localizing almost exactly with
sIgM. Some of the CMTM7 were internalized into cytoplasm by
5 minutes after the initiation of the culture, but others remaining
on the plasma membrane were concomitantly segregated with
sIgM into clusters. By 15 minutes, sIgM was internalized with the
surface CMTM7 and mostly co-localized with CMTM7 at
vesicular structures in the cytoplasm (Figure 1C). The observed
tight association of sIgM and CMTM7 during the active sIgM
movement strongly suggests a physical interaction between the
two molecules.
CMTM7 is required for BLNK phosphorylation by Syk and
for signal transduction upon sIgM ligation
To investigate the function of CMTM7 in B cells, we generated
BAL17 transductants in which CMTM7 gene expression was
suppressed by shRNAs targeting two independent sequences (kd1
and kd2), as well as cells transduced with a control shRNA vector
(mock) (Figure 2A). We found that BCR-ligation-induced
tyrosine-phosphorylation of several proteins was attenuated in
the CMTM7-knockdown cells as compared with the mock-
transduced cells (Figure 2B and Figure S1A). Activation-
associated phosphorylation of ERK and JNK was greatly
attenuated and that of PLCc2 was moderately, whereas that of
Src-family kinases (SFK) and Syk were unaffected by CMTM7
knockdown (Figure 2C and Figure S1B). In addition, BCR-
induced tyrosine-phosphorylation of BLNK was greatly attenuated
in the CMTM7-knockdown cells (Figure 2D and Figure S1C),
which was attributable to impaired association of BLNK with Syk
(Figure 2E and Figure S1D). Moreover, reciprocal immuno-
precipitation experiments demonstrated association of CMTM7
and BLNK, which was augmented after sIgM-ligation (Figure 2F
and 2G). These data strongly suggest that, upon sIgM-ligation,
CMTM7 functions to recruit BLNK to the plasma membrane in
the vicinity of BCR-bound Syk and thus facilitate BLNK
phosphorylation by Syk.
The C-terminal region of CMTM7 is necessary for its
membrane localization and for BLNK phosphorylation
To further investigate the mode of CMTM7 interaction, we
made expression vectors that encode T7-tagged full length (full)
CMTM7, and mutants lacking the N-terminal (DN) or the C-
terminal (DC) putative extracellular regions. A silent mutation at
the shRNA recognition site was introduced into the full and DN
constructs to prevent their recognition and silencing by the shRNA
(Figure 3A). When transiently expressed in HeLa cells, the full
and DN versions of CMTM7 were localized to the plasma
membrane and perinuclear regions as described above, whereas
the DC version was diffusely localized in the cytosol and the
nucleus (Figure 3B). We transfected these constructs into
CMTM7-knockdown BAL17 (kd1) cells and made stable clones
expressing the full, DN, or DC versions of CMTM7 proteins.
These clones as well as the original BAL17 and parental kd1 cells
expressed equivalent levels of BLNK and IgM H chain proteins
(Figure 3C). A subcellular fractionation experiment confirmed
that most of the full and DN CMTM7 proteins were present in the
membrane fraction, whereas the DC was exclusively in a cytosolic
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DN CMTM7 were bound with BLNK but not Lyn (Figure 3E).
BCR-induced BLNK association with Syk was restored in the kd1
cells reconstituted with the full or the DN, but not the DC,
CMTM7 (Figure 3F), indicating that the C-terminal domain of
CMTM7, or membrane localization of CMTM7, is critical for the
binding of both proteins. Accordingly, BCR-induced tyrosine-
phosphorylation of BLNK and ERK activation were fully restored
in the kd1 cells reconstituted with the full or the DN, but not the
DC, CMTM7 (Figure 3G and 3H).
CMTM7 is associated with sIgM and recruits BLNK
It is well known that, upon ligation of IgM, Syk is recruited to
the Iga/Igb subunits of the IgM BCR complex via binding to
phosphorylated ITAMs in their cytoplasmic tails [3]. Therefore,
the observed CMTM7-dependent interaction of BLNK with Syk
Figure 1. CMTM7 is localized at the plasma membrane in association with clathrin and sIgM. (A) HeLa cells stably expressing T7-hCMTM7
were fixed, permeabilized, and stained with antibodies for the indicated organelle makers (left panels) and T7 tag (middle panels) as described in the
Materials and Methods section. Right panels: merged images. (B) HEK293T cells transiently expressing mouse CMTM7 tagged with HA or FLAG
epitopes at the N- or C-termini, respectively, or not (schematically represented at the top), were stained with anti-HA antibody (left) or anti-FLAG
antibody (right) and analyzed by flow cytometry. The histograms indicate fluorescence intensities for non-tagged (red lines), and HA- (blue lines) or
FLAG- (green lines) tagged CMTM7s. The predicted plasma membrane topology of CMTM7 is depicted at the bottom. (C) BAL17 cells stably
expressing T7-tagged mouse CMTM7 (BAL17/T7-CMTM7) were stained with rabbit anti-T7 and biotin-anti-IgM antibodies, and incubated at 37uC for
the indicated time periods. Then the cells were fixed, permeabilized, and stained with TRITC-anti-rabbit IgG and FITC-streptavidin. The fluorescence
FITC (top), TRITC (middle), and their merged images (bottom) are shown.
doi:10.1371/journal.pone.0031829.g001
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complex and thus mediates interaction of BLNK and Syk. Indeed,
mH chain was co-precipitated with CMTM7 from BAL17/T7-
CMTM7 cell lysates (Figure 4A), and CMTM7 was present in
the surface IgM complex in the same cells irrespective of sIgM
ligation (Figure 4B). Although both full and DN CMTM7 was co-
precipitated with sIgM in the reconstituted kd1 cells, DC CMTM7
was not (Figure 4C). Furthermore, BLNK was co-precipitated
with the sIgM in the BAL17/T7-CMTM7 cells (Figure 4B) and
the kd1 cells reconstituted with the full or DN, but not DC,
Figure 2. CMTM7 is required for BLNK association with Syk, its phosphorylation and signal transduction from BCR. (A) Expression
levels of endogenous CMTM7 mRNA in parental, mock-transduced, and in two independent CMTM7-knockdown BAL17 cells (kd1 and kd2) evaluated
by real-time RT-PCR. (B, C, D, E) The kd1 or the mock-transduced BAL17 cells were stimulated with anti-IgM antibody for the indicated time periods.
(B, C) The cell lysates were subjected to Western blot analysis with antibodies against the indicated molecules. pY: total phosphotyrosines detected
by the PY20 antibody; SFK: src-family kinase. (D, E) The cell lysates were immunoprecipitated (IP) with anti-BLNK antibody or control rabbit IgG (D), or
with anti-Syk antibody (E), and the precipitates and the lysates were subjected to Western blot analysis with the indicated antibodies. (F, G) BAL17/T7-
CMTM7 cells were stimulated with anti-IgM for 10 min or untreated (0 min), and the cell lysates were immunoprecipitated (IP) with the indicated
antibodies or species- and isotype-matched control antibodies and analyzed as in (E). (C, D) Numbers below each panel represent relative
phosphorylation values of each protein (setting the value of the left-most sample in each panel as 1.0), normalized as relative to the corresponding
total proteins as described in the Materials and Methods, except for pSFK which contains the undefined number of Src-family proteins.
doi:10.1371/journal.pone.0031829.g002
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complex is dependent on CMTM7 integrated in the plasma
membrane.
Discussion
BLNK has been characterized as a multivalent adaptor protein
that plays a pivotal role in signal transduction from BCR of the
IgM class. It has been demonstrated that Syk is the dominant
tyrosine kinase that phosphorylates BLNK and that this
phosphorylation is mandatory for the BLNK adaptor function
[26]. However, less is known how BLNK is initially recruited to
the sIgM complex, to which Syk is already recruited and thereby
activated, after ligation of the BCR. Here we have identified a
previously unknown transmembrane protein CMTM7 as the
missing link between BLNK and the BCR. We demonstrated that
Figure 3. The C-terminal region of CMTM7 is necessary for its membrane localization and function. (A) Schematic representation of the
mouse CMTM7 cDNA, and a T7-tagged (indicated by a blue globule) full-length version (full) or deletion mutants lacking the N-terminal (DN) or the C-
terminal (DC) putative extracellular portions. Double point mutations (indicated in red) were introduced at the shRNA recognition site of the full and
the DN CMTM7s. (B) HeLa cells transiently transfected with the full, DN, or DC CMTM7s were fixed, permeabilized, stained with anti-T7 antibody, and
analyzed by confocal microscopy. (C) Western blot analysis of BAL17 cells, kd1 cells, and the latter reconstituted with the CMTM7 forms shown in (A).
Antibodies against BLNK, IgM H chain (m H), b-actin, and T7 tag (for the exogenous CMTM7s) were used for detection. (D) The reconstituted kd1 cells
were fractionated into membrane and cytosol, and the lysates of both fractions were subjected to Western blot analysis using antibodies against Lyn
and the T7-tag. (E) The same cells as in (D) were stimulated with anti-IgM for 1 min, and the lysates of the membrane fractions of these cells were
immunoprecipitated with anti-T7 antibody [IP:T7(CMTM7)]. The precipitates and the lysates, as well as a cytosol fraction of the ‘full’ cells (the most
right lane), were analyzed as in (D) with the addition of an anti-BLNK antibody. (F, G, H) BAL17 cells and the reconstituted kd1 cells were stimulated
with anti-IgM antibody for the indicated time periods and the cell lysates were immunoprecipitated with the indicated antibodies (IP). The
precipitates (F, G) and the lysates (F, H) were analyzed by Western blotting for the presence of BLNK and Syk (F), tyrosine-phosphorylated (pBLNK)
and total BLNK (G), or activated (pERK) and total ERK (H). (G, H) Numbers below the panels represent relative phosphorylation values of each protein
(setting the value of the left-most sample in each panel as 1.0), normalized as relative to the corresponding total proteins as described in the
Materials and Methods.
doi:10.1371/journal.pone.0031829.g003
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interaction with and phosphorylation of BLNK, and ultimately for
activation of downstream MAP-kinases after sIgM ligation
(Figure 5). Confocal microscopy data indicated a tight association
of the two proteins in the plasma membrane as well as in the
membrane of vesicles trafficking through the cytoplasm. Although
the diffuse cytoplasmic localization of BLNK hampered confocal
microscopic visualization of its plasma membrane recruitment,
biochemical analyses clearly demonstrated that BLNK is bound
with CMTM7 in the membrane fraction, and also that BLNK is
associated with the sIgM complex only when CMTM7 is normally
integrated in the plasma membrane. These data strongly suggest
that CMTM7 is a part of sIgM complex that binds BLNK for its
phosphorylation by Syk and to nucleate the ‘signalosome’.
BLNK has been shown to directly bind to Iga [14–16] or to Syk
[20,21] via its SH2 domain. While these interactions appear to be
biologically significant, they do not appear to be essential for
BLNK phosphorylation since BLNK lacking the SH2 domain
could still be phosphorylated in B cells upon BCR ligation [20].
Likewise, the N-terminal leucine zipper motif of BLNK, a requisite
for its plasma-membrane association [22], is not essential for
BLNK phosphorylation [20]. Nevertheless, given their consider-
able contributions to BLNK phosphorylation, these interactions
are likely involved in the process whereby BLNK is recruited to
the sIgM complex and interacts with Syk, in addition to the
CMTM7-BLNK interaction demonstrated in the present study.
Whether these interactions represent different steps of the process
leading to full BLNK phosphorylation, or are redundant
mechanisms for this process, remains to be examined. Our data
demonstrated that BLNK is co-precipitated with CMTM7 before
sIgM ligation but that the amount of co-precipitate increased after
the ligation. It appears that crosslinking of sIgM causes multi-
merization of the associated CMTM7, which may stabilize the
binding of BLNK. BLNK SH2 domain-mediated binding to Iga
and/or Syk may further stabilize the association of BLNK with the
sIgM complex.
Figure 4. CMTM7 binds to sIgM and recruits BLNK to sIgM. (A) BAL17/T7-CMTM7 cells were stimulated with anti-IgM antibody for 10 min or
untreated (0 min). Then the cell lysates were immunoprecipitated with mouse anti-T7 (IP: T7) or an isotype-matched control (IP: cont.) monoclonal
antibodies. The precipitates and the lysate were analyzed by Western blot analysis. (B, C) BAL17/T7-CMTM7 cells (B) or the kd1 cells reconstituted with
the indicated forms of CMTM7 (C) were treated with goat anti-IgM antibody (whole IgG) or untreated (-) and incubated at 37uC for the indicated time
periods, or kept on ice (0 min). Then the cell lysates were incubated with protein G-coated beads. The bead-bound proteins (IP: IgM or -) and the
lysates were analyzed by Western blot analysis using antibodies against m H chain, T7 tag, and BLNK as indicated.
doi:10.1371/journal.pone.0031829.g004
Figure 5. A model for the CMTM7 function in the B cell receptor
complex. CMTM7 is associated with sIgM where it mediates interaction
of BLNK and Syk, as well as BLNK phosphorylation by Syk, which is
necessary for eventual activation of ERK and JNK, in part through PLCc2
activation. Arrows with solid and dotted lines indicate direct and
indirect interactions, respectively.
doi:10.1371/journal.pone.0031829.g005
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after sIgM ligation suggests a direct interaction of the two proteins,
although we have not yet identified the region(s) in these proteins
that are involved in this interaction. It was previously reported that
the membrane-proximal C m 4 domain of the m H chain constant
region is critical for the assembly of immobile sIgM oligomers that
are competent for signaling when bound by monovalent,
membrane-tethered antigens [27]. Although the mechanism for
the C m 4 domain-mediated sIgM oligomerization remains
unknown, it may be mediated by integral membrane proteins
that bind to this domain. It is tempting to speculate that CMTM7
binds to the C m 4 domain of sIgM through its extracellular regions
and thereby mediates oligomerization of the sIgM. We demon-
strated that the CMTM7 DC mutant lacking the C-terminal
extracellular region failed to associate with sIgM (Figure 4C), but
the interpretation of this data is complicated by the fact that the
DC variant is also not integrated into the plasma membrane. This
might indicate that the C-terminal region of CMTM7 is necessary
for the association with sIgM and this association is required for
initial membrane integration of nascent CMTM7 at ER. This
explanation would be unlikely, however, without a supposition
that the C-terminal region can also be associated with other
membrane receptor(s) expressed in HeLa cells (see Figure 3B).
Alternatively, the C-terminal region may be intrinsically required
for the membrane integration of CMTM7, although there has
been no evidence that a C-terminal region neighboring the last
transmembrane domain is necessary for the membrane integration
of multi-spanning proteins. If the latter is the case, the role of the
C-terminal region of CMTM7 in sIgM association remains
obscure. Thus, further study is necessary to determine the
molecular basis for the interaction of CMTM7 and sIgM.
Our confocal microscopy analysis indicated that CMTM7 is
also associated with clathrin (Figure 1A) and co-internalized with
sIgM after its ligation, although the majority of the sIgM-CMTM7
complex appears to remain on the cell surface at least for ten
minutes after sIgM ligation before it is internalized (Figure 1C).
Therefore, CMTM7 may also play some role in the process of
clathrin-mediated sIgM internalization, but well after the early
phase of BCR-mediated signal transduction. Concerning its role in
ligation-induced sIgM internalization, we observed that this
process was delayed in BAL17 cells overexpressing CMTM7
and, conversely, was accelerated in the CMTM7-knockdown
BAL17 cells. Normal kinetics could by restored by reconstitution
of the knockdown cells with full or DN, but not DC, forms of
CMTM7 (our unpublished data). Thus, it appears that CMTM7,
perhaps with associated BLNK, negatively regulates sIgM
internalization to retain the BLNK-nucleated signalosome at the
plasma membrane for the requisite time period required for
optimal signal transduction. After that point, sIgM is presumably
dissociated from Iga/b, which remains at the plasma membrane
[28,29], CMTM7 dissociates from BLNK, which is now bound to
Iga, and then the sIgM, accompanied by CMTM7, may be
endocytosed via clathrin-coated pits and vesicles and delivered to
early endosomes.
We previously identified CMTM3, another member of the
CMTM protein family, as a binding partner of BLNK, and
showed that it binds to an N-terminal part of BLNK [23]. We
observed that the expression level of CMTM3 mRNA is relatively
low compared to that of CMTM7 in BAL17 cells, while it is
relatively high in the DC2.4 dendritic cell line (our unpublished
data). Indeed, according to the expression profiles in the RefDIC
public database (http://refdic.rcai.riken.jp/welcome.cgi), CMTM7
is highly expressed in almost all hematopoietic lineage cells, but
high expression of CMTM3 is restricted to dendritic cells and
macrophages. Therefore, CMTM7 appears to play a more
dominant role in B cells than CMTM3. On the other hand,
CMTM3 may be more important in dendritic cells and
macrophages, in which BLNK as well as an analogous adaptor
protein SLP76 are expressed. In this regard, we found that
CMTM3, but not CMTM7, binds also to SLP76 in DC2.4 cells
and Raw263.7 macrophage cells (our unpublished data). We have
observed distinct functions of BLNK and SLP76 in endocytosis
and signaling through a cell-surface receptor in dendritic cells
(manuscript in preparation), a finding that might be related to the
different binding preferences of these adaptor molecules for
CMTM3 and CMTM7.
Materials and Methods
Antibodies
The following antibodies were used: mouse anti-GM130, HRP-
conjugated mouse anti-phosphotyrosine (PY20) (BD Biosciences);
goat anti-EEA1 (C-15), goat anti-Btk (C-20), rabbit anti-ERK2 (C-
14), rabbit anti-JNK1 (C-17), rabbit anti-Syk (N-19), rabbit anti-
PLCc2 (Q-20), rabbit anti-Lyn (44), FITC-conjugated donkey
anti-goat IgG (Santa Cruz Biotechnology); rabbit anti-phospho-
p44/42 MAPK (Thr202/Try204), rabbit anti-phospho-PLCc2
(Tyr1217), rabbit anti-phospho-SAPK/JNK (Tyr183/Tyr185),
rabbit anti-phospho-ZAP70/Syk (Tyr319/352), rabbit anti-phos-
pho-Src (Tyr416) (Cell Signaling Technology); mouse anti-
calnexin, rabbit anti-T7 (Chemicon); mouse anti-FlagM2 (Sig-
ma-Aldrich); mouse anti-clathrin (Abcam); mouse anti-T7 (Nova-
gen); goat anti-HA (Bethyl Laboratories); goat F(ab9)2 anti-mouse
IgM, TRITC-conjugated donkey anti-rabbit IgG, HRP-conjugat-
ed goat anti-rabbit IgG (Jackson ImmunoResearch); biotin-goat
F(ab9)2 anti-mouse IgM, FITC-conjugated goat anti-mouse IgG,
HRP-conjugated goat anti-mouse IgM (Southern Biotech); goat
anti-mouse IgM (Cappel); HRP-conjugated rabbit anti-mouse IgG
(Zymed); FITC-conjugated streptavidin (Biolegend); rabbit anti-
BLNK (Hayashi et al., 2000).
Cell culture
BAL17 [30], HeLa [31] and HEK293T [32] cells were obtained
from Dr. Takeshi Watanabe (Graduate School of Medicine, Kyoto
University). BAL17 cells and their derivatives were incubated in
RPMI1640 medium, and HeLa and HEK293T cells in DMEM,
each supplemented with 10% FBS (Biological Industries) and
penicillin/streptomycin. RPMI1640 medium also contained
50 mM 2-mercaptoethanol. For B-cell stimulation, B cells were
treated with 10 mg/ml of goat F(ab9)2 anti-mouse IgM, unless
otherwise noted.
Real time RT-PCR
cDNA was synthesized with ReverTra Ace (Toyobo). Real-time
PCR was performed with an Applied Biosystems 7500Fast. To
amplify CMTM7 cDNA, the following primers were used:
59agatggtcaccctgctgatt39 and 59caggtgagcacacggtagaa39.
Plasmid constructions
The human CMTM7 (hCMTM7), mouse CMTM7
(mCMTM7) and its variants (DN; 38–168 aa, DC; 1–152 aa)
were cloned into the pCAT7 vector [23]. The mCMTM7 and
those appended with an N-terminal HA-tag or a C-terminal
36FLAG-tag via a glycine/serine linker (GGGGS) were also
cloned into a pcDNA3.1 vector. To generate CMTM7-knockdown
cells (kd1 and kd2), short hairpin (shRNA)-expressing retroviral
vectors were constructed using the pSIREN-RetroQ vector
(Clontech) and the following RNA interference sequences: for
CMTM7: A Transmembrane Linker of BLNK and BCR
PLoS ONE | www.plosone.org 7 February 2012 | Volume 7 | Issue 2 | e31829mCMTM7,5 9acccagtcttcagatgcatct39 (shRNA-1 for kd1) and
59gccttcatctgtgtacgaagc39 (shRNA-2 for kd2); and for an irrelevant
sequence (luciferase) used for mock-transduction, 59gtgcgttgctagtac-
caac39. To reconstitute the kd1 cells, the mCMTM7 sequence was
mutated at the shRNA-1 targeting site by PCR using two
complementary primers, 59cctgtataacccagtcgtcggatgcatctgcctg39
and 59caggcagatgcatccgacgactgggttatacagg39 (mutated nucleotides
are indicated by bold letters), pCAT7-mCMTM7 and pCAT7-
mCMTM7 DN as templates, and KOD polymerase (Toyobo).
PCR products were treated with Dpn1 to digest the template DNA
and used for bacterial transformation. The CMTM7 sequences of
the resultant clones were verified by nucleotide sequencing.
Transfection
HeLa cells were transfected with a pCAT7-based plasmid by
Trans IT-LT1 (Invitrogen), and the cells expressing hCMTM7
were bulk selected with G418 (10 mg/ml) as indicated. BAL17 cells
were transfected by electroporation (250 V, 950 mF) with pCAT7-
based plasmids and clonally selected with G418 (1 mg/ml). The
shRNA-expressing retroviral vectors were transduced as described
[33] into BAL17 cells, which were then bulk selected with
puromycin (20 mg/ml). HEK293T cells were transiently transfect-
ed with pcDNA3.1-based plasmids by Hily Max (Dojindo).
Immunoprecipitation and Western blot analysis
Immunoprecipitations were performed as described [19]. The
immunoprecipitated proteins and/or cell lysates were resolved by
SDS-PAGE, transferred onto polyvinylidene fluoride membranes,
probed with the indicated horseradish peroxidase (HRP)-labeled
or unlabeled antibodies, and with the secondary HRP antibodies
for the latter, and the signals were visualized with Western
Lightning Chemiluminescence Reagent Plus (PerkinElmer). The
blot was stripped off and reprobed with other antibodies as
indicated. The chemiluminescence of the protein bands was
detected and imaged by LAS-3000 (Fujifilm), the intensities of
which were quantified using the Science Lab 2001 Image Gauge
software (Fujifilm). The values of the intensities of phosphorylated
proteins were normalized as relative to those of the corresponding
total proteins, and expressed as relative values in each data.
Immunofluorescence microscopy
HeLa cell transfectants cultured on glass-bottomed dishes were
fixed with 4% paraformaldehyde, permeabilized with 0.1%
TrironX-100, then stained with rabbit anti-T7 and the other
indicated antibodies, and then with TRITC-anti-rabbit IgG
antibody and appropriate FITC-labeled secondary antibodies.
BAL17 cell transfectants were stained with biotin-goat F(ab9)2 anti-
mouse IgM and rabbit anti-T7 antibodies on ice, incubated at
37uC for the indicated time periods, or kept on ice (for 0 min),
then fixed with 4% paraformaldehyde and permeabilized with
0.1% Tween-100, and stained with anti-FccRII/III blocking Ab
(2.4G2). The cells were then incubated with blocking buffer (5%
skim milk in PBS), stained with TRITC-anti-rabbit IgG antibody
and FITC-streptavidin, extensively washed, and finally placed on
slide glasses and coverslipped. The samples were analyzed with a
Leica TCS SP2 confocal laser-scanning microscope (CLSM) using
a6 3 6objective.
Subcellular fractionation
For preparation of subcellular fractions, cells were suspended in
hypotonic solution (20 mM Tris, 5 mM EDTA, 5 mM EGTA) for
10 min, passed through a 26-gauge needle for 15 strokes on ice,
and centrifuged at 10,0006g for 5 min at 4uC. The supernatant
fraction was further centrifuged at 110,0006g for 15 min at 4uC.
The pellet and supernatant were used as membrane and
cytoplasmic fractions, respectively. The membrane fraction was
solubilized with 1% TNE buffer containing 1% NP-40 [19].
All the data shown are representative of three or more
independent experiments
Supporting Information
Figure S1 CMTM7 is required for BLNK association
with Syk, its phosphorylation and signal transduction
from BCR. (A, B, C, D) The CMTM7-knockdown (kd2) or
mock-transduced BAL17 cells were stimulated with anti-IgM
antibody for the indicated time periods and then analyzed as in
Figure 2 (B, C, D, E).
(TIF)
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